O-Acetyl-GD2 as a Therapeutic Target for Breast Cancer Stem Cells
SynopsisA sugar-lipid molecule called OAcGD2 is a novel marker for breast cancer stem cells. Treatment with anti-OAcGD2 mAb8B6 may have superior anticancer efficacy by targeting cancer stem cells, thereby reducing metastasis and recurrence of cancer.BackgroundCancer stem cells (CSCs) that drive tumo...
Main Authors: | Jing-Yan Cheng, Jung-Tung Hung, Juway Lin, Fei-Yun Lo, Jing-Rong Huang, Shih-Pin Chiou, Ya-Hui Wang, Ruey-Jen Lin, Jen-Chine Wu, John Yu, Alice L. Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.791551/full |
Similar Items
-
Differential O- and Glycosphingolipid Glycosylation in Human Pancreatic Adenocarcinoma Cells With Opposite Morphology and Metastatic Behavior
by: Tao Zhang, et al.
Published: (2020-06-01) -
Glycosphingolipid–Protein Interaction in Signal Transduction
by: Domenico Russo, et al.
Published: (2016-10-01) -
Glycosphingolipids in human parasites
by: Richard D. Cummings
Published: (2023-09-01) -
Dissecting the conformation of glycans and their interactions with proteins
by: Sheng-Hung Wang, et al.
Published: (2020-09-01) -
Editorial: The role of glycans in infectious disease, Volume II
by: Iván Martínez-Duncker, et al.
Published: (2022-11-01)